mash

Documents about mash

• Resmiterom Efficacy & Safety in Patients With MASH#874969ClinicalTrials.gov
• Global Research Initiative for Patients Screening on MASH#451565ClinicalTrials.gov
• Nutrition Intervention Combined With Resmetirom for MASH#858567ClinicalTrials.gov
• Influence of Moisture Content on Some Physical Properties of Pineapple Pomace Based Mash#289871University of Ibadan Institutional Repository
• Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH#851599ClinicalTrials.gov
• The Metaphysics of Mash‐Ups#698395PhilArchive
• A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)#826148ClinicalTrials.gov
• System-Level Considerations for MASH Assessment#388564NCBI Bookshelf
• A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH#889805ClinicalTrials.gov
• A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)#895892ClinicalTrials.gov
• Thermoacoustic Method for Estimating Liver Fat Fraction#991699ClinicalTrials.gov
• A 1-1 MASH 2-D Vernier Time-to-Digital Converter with 2nd-order noise shaping#385055Lund University Publications
• ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)#807011ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH#888266ClinicalTrials.gov
• Metabolic Dysfunction-Associated Steatohepatitis (MASH) GeoMx and COMET Dataset#211387KU Leuven RDR Dataverse OAI Archive
• A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)#889606ClinicalTrials.gov
• Mitochondrial dysfunction and lipid droplet dynamics in MASH: HSD17B13 as a therapeutic target.#433992NCBI PubMed Central
• Plasma-targeted proteomic and lipidomic profiling of MASLD, MASH, and hepatitis C virus infection.#193728NCBI PubMed Central
• Signature gene expression model for quantitative evaluation of MASH-like liver injury in mice.#280898NCBI PubMed Central
• Clinical Classification of MAFLD Based Liver Biopsy#290888ClinicalTrials.gov
• SELECTIVE MTOR INHIBITION VIA FLCN DRIVES TFE3-DEPENDENT VLDL-TG SECRETION AND PROTECTS FROM MAFLD/MASH#929177ScholarlyCommons
• Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR)#802659ClinicalTrials.gov
• Differential candidate characteristics associated with increasing ALD and MASH among liver transplant listings in the US.#148289NCBI PubMed Central
• The "Direct Structural Disruption" Hypothesis: Bacteroides fragilis Toxin as a Potentiating Cofactor in MASH Pathogenesis.#232452NCBI PubMed Central
• Bile acid-axis dysregulation in MASLD/MASH progression: from metabolic mismatch to inflammatory-fibrotic remodeling.#636334NCBI PubMed Central
• Study of the Link Between MASH ( Metabolic Dysfunction-Associated Steatohepatitis) and MAMs (Mitochondria-Associated Membranes ) Alteration in Patients Undergoing Bariatric Surgery - MAMBA#801713ClinicalTrials.gov
• Profiling of extracellular vesicles from primary hepatocytes, organoids, and mash patients identifies cell injury-specific signatures.#262945NCBI PubMed Central
• Minocycline for Aneurysmal Subarachnoid Hemorrhage (MASH)#826744ClinicalTrials.gov
• Safety, Tolerability, PK, PD, and Immunogenicity of QL2401 in Healthy Chinese Adults#1008963ClinicalTrials.gov
• Evaluating the Pharmacokinetics and Safety of Miricorilant#894418ClinicalTrials.gov
• Glimpse into the role of Kupffer cells in a spheroid model of metabolic dysfunction-associated steatohepatitis (MASH).#323057NCBI PubMed Central
• Restoring lysosomal proteostasis reverses steatohepatitis and fibrosis in experimental MASH#652793HAL (France)
• ApoJ and apoL1 as novel determinants of MASH: a cross-sectional study#124240HAL (France)
• MASH Suite: A User-Friendly and Versatile Software Interface for High-Resolution Mass Spectrometry Data Interpretation and Visualization#384194CiNii
• CD44 in Group 1 Innate Lymphoid Cells Impacts the Development and Progression of Steatohepatitis#257412HAL (France)
• Management of patients with type 2 diabetes and MASLD: An overview and joint statement#129472HAL (France)
• Machine learning-based prediction model for drug target identification and MASH improvement: a comprehensive analysis of biochemical and ferroptosis/autophagy biomarkers.#143180NCBI PubMed Central
• Clinical AI-assisted FXR prioritization and WADDAICA-guided design of a berberine-inspired analogue for MASH: integrated computational and experimental validation.#436981NCBI PubMed Central
• Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD#321613ClinicalTrials.gov
• Innate Immune Function and the Gut Microbiome in Metabolic Dysfunction Associated Steatotic Liver Disease#186514Research Repository UCD
• Extracellular vesicles carrying surface-anchored adiponectin prevent obesity-related metabolic complications by enhancing insulin sensitivity#315104HAL (France)
• Acceptability and Feasibility of a New Approach to Engage Patients With Steatotic Liver Disease in Physical Activity#980737ClinicalTrials.gov
• Replication data for: The impact of unit operations during processing on (deep-fried) potato mash properties#644678KU Leuven RDR Dataverse OAI Archive
• Replication data for: The impact of post-harvest potato storage on (deep-fried) potato mash properties#644684KU Leuven RDR Dataverse OAI Archive
• Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)#126028ClinicalTrials.gov
• Design, testing, and safety performance of movable guardrail systems: A PRISMA-based systematic review#197602Research Online
• The Development of MASLD Among Survivors of Breast or Colorectal Cancer#343833ClinicalTrials.gov
• A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups.#968504ClinicalTrials.gov
• Growth Performance and Nutrient Utilisation of African Giant Land Snail (Archachatina marginata) Fed Grower Mash Partially Replaced with Crab and Kitchen Wastes#329001African Journals Online
• Additional file 1 of Co-production of high-purity floridoside and isofloridoside ameliorates MASH via Parabacteroides goldsteinii-UDCA-FXR enterohepatic axis#377662Figshare